Neoatherosclerosis: From basic principles to intravascular imaging

Minerva Cardioangiologica

Volumn 66, Issue 3, 2018, Pages 292-300

  Nicol, Philipp ^a   Xhepa, Erion ^a   Bozhko, Dmitry ^a   Joner, Michael ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angioplasty; Balloon; Coronary; Molecular imaging; Optical coherence; Tomography

Indexed keywords

ATHEROSCLEROSIS; AUTOFLUORESCENCE IMAGING; CELL INFILTRATION; EQUIPMENT DESIGN; HISTOPATHOLOGY; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MOLECULAR IMAGING; NEAR INFRARED SPECTROSCOPY; NEOATHEROSCLEROSIS; NEOINTIMA; NEOVASCULARIZATION (PATHOLOGY); OPTICAL COHERENCE TOMOGRAPHY; REVIEW; STENT THROMBOSIS; DIAGNOSTIC IMAGING; ECHOGRAPHY; PATHOLOGY; PROCEDURES; RESTENOSIS; STENT;

ATHEROSCLEROSIS; CORONARY RESTENOSIS; HUMANS; NEOINTIMA; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY;

EID: 85047780200     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: 10.23736/S0026-4725.17.04573-X     Document Type: Review

References (56)

1. Gröntzig A. Transluminal dilatation of coronary-Artery stenosis. Lancet 2017;311:263.
2. Horlitz M, Sigwart U, Niebauer J. Fighting restenosis after coronary angioplasty: contemporary and future treatment options. Int J Cardiol 2017;83:199-205.
3. Serruys PW, Jaegere P de, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloonexpandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331.
4. Morice MC, Serruys PW, Sousa E, Fajadet J, Hayashi EB, Perin M, et al. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
5. Stone GW, Ellis SG, Cox DA, Hermiller J, OShaughnessy C, Mann JT, et al. A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease. N Engl J Med 2004;350:557-68.
6. Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and secondgeneration drug-eluting stents: Results from a registry of 18, 334 patients. JACC Cardiovasc Interv 2013;6:1267-74.
7. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants: Bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-22.
8. Cook S, Eshtehardi P, Kalesan B, Räber L, Wenaweser P, Togni M, et al. Impact of incomplete stent apposition on long-Term clinical outcome after drug-eluting stent implantation. Eur Heart J 2012;33:1334-43.
9. Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R, et al. Arterial neovascularization and inflammation in vulnerable patients: Early and late signs of symptomatic atherosclerosis. Circulation 2004;110:2843-50.
10. Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: Implications for plaque vulnerability. Circulation 2004;110:2032-8.
11. Yahagi K, Kolodgie FD, Otsuka F, Finn A V, Davis HR, Joner M, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol 2016;13:79-98.
12. Inoue K, Abe K, Ando K, Shirai S, Nishiyama K, Nakanishi M, et al. Pathological analyses of long-Term intracoronary Palmaz-Schatz stenting: Is its efficacy permanent? Cardiovasc Pathol 2004;13:109-15.
13. Nakazawa G, Ladich E, Finn AV, Virmani R. Pathophysiology of vascular healing and stent mediated arterial injury. EuroIntervention 2008;4:C7-10.
14. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drugeluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41.
15. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of Drug-Eluting Stents in Humans. Delayed Healing and Late Thrombotic Risk. J Am Coll Cardiol 2006;48:193-202.
16. Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-And paclitaxel-eluting stents in humans. Circulation 2014;129:211-23.
17. Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K, et al. Long-Term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 2002;105:2986-91.
18. Ramcharitar S, García-García HM, Nakazawa G, Kukreja N, Ligthart JMR, Virmani R, et al. Ultrasonic and pathological evidence of a neo-intimal plaque rupture in patients with bare metal stents. EuroIntervention 2007;3:290-1.
19. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, et al. Appearance of Lipid-Laden Intima and Neovascularization After Implantation of Bare-Metal Stents. Extended Late-Phase Observation by Intracoronary Optical Coherence Tomography. J Am Coll Cardiol 2009;55:26-32.
20. Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Predictors for neoatherosclerosis: A retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging 2012;5:660-6.
21. Jiménez JM, Davies PF. Hemodynamically driven stent strut design. Ann Biomed Eng 2009;37:1483-94.
22. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pr Cardiovasc Med 2009;6:16-26.
23. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A Prospective Natural-History Study of Coronary Atherosclerosis. N Engl J Med 2011;364:226-35.
24. Kwon SW, Kim BK, Kim TH, Kim JS, Ko YG, Choi D, et al. Qualitative assessment of neointimal tissue after drugeluting stent implantation: Comparison between followup optical coherence tomography and intravascular ultrasound. Am Heart J 2011;161:367-72.
25. Araki T, Nakamura M, Sugi K. Characterization of instent neointimal tissue components following drugeluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system. J Cardiol 2014;64:423-9.
26. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging 2012;5:71-82.
27. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-93.
28. Habara M, Terashima M, Nasu K, Kaneda H, Inoue K, Ito T, et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: An optical coherence tomography study. Circ Cardiovasc Interv 2011;4:232-8.
29. Habara M, Terashima M, Nasu K, Kaneda H, Yokota D, Ito T, et al. Morphological differences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug-eluting stent implantation: An optical coherence tomography study. Eur Heart J Cardiovasc Imaging 2013;14:276-84.
30. Parma L, Baganha F, Quax PHA, de Vries MR. Plaque angiogenesis and intraplaque hemorrhage in atherosclerosis. Eur J Pharmacol 2016;1-9.
31. Tian J, Ren X, Uemura S, Dauerman H, Prasad A, Toma C, et al. Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics: Optical coherence tomography study. Am Heart J 2014;167:884-892.e2.
32. Gao L, Park SJ, Jang Y, Lee S, Kim CJ, Minami Y, et al. Comparison of Neoatherosclerosis and Neovascularization between Patients with and Without Diabetes An Optical Coherence Tomography Study. JACC Cardiovasc Interv 2015;8:1044-52.
33. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, et al. Optical coherence tomographic analysis of instent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011;123:2954-63.
34. Lutter C, Mori H, Yahagi K, Ladich E, Joner M, Kutys R, et al. Histopathological Differential Diagnosis of Optical Coherence Tomographic Image Interpretation After Stenting. JACC Cardiovasc Interv 2016;9:2511-23.
35. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary Optical Coherence Tomography: A Comprehensive Review Clinical and Research Applications. J Am Coll Cardiol Intv 2009;2:1035-46.
36. Malle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, et al. Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol 2013;33:1376-83.
37. van Soest G, Goderie T, Regar E, Koljenović S, van Leenders GLJH, Gonzalo N, et al. Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging. J Biomed Opt 2010;15:11105.
38. Gnanadesigan M, Kameyama T, Karanasos A, Van Ditzhuijzen NS, Van Der Sijde JN, Van Geuns RJ, et al. Automated characterisation of lipid core plaques in vivo by quantitative optical coherence tomography tissue type imaging. EuroIntervention 2016;12:1490-7.
39. Kim Y, Gnanadesigan M, van Soest G, Johnson TW. A new technique for lipid core plaque detection by optical coherence tomography for prevention of peri-procedural myocardial infarction. Medicine (Baltimore) 2017;96:e7125.
40. Bourantas CV. Neointima and neoatherosclerotic characteristics in bare metal and first and second generation drug eluting stents in patients admitted with cardiovascular events attributed to stent failure: An optical coherence tomography study. EuroIntervention 2017 Jun 13 [Epub ahead of print].
41. Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol 2012;110:933-9.
42. Fu Q, Suzuki N, Kozuma K, Miyagawa M, Nomura T, Kawashima H, et al. Quantitative optical coherence tomography analysis for late in-stent restenotic lesions. Int Hear J 2015;56:13-7.
43. Waxman S, Caplan J, Waxman S, Ishibashi F, Caplan JD. Rationale and use of near-infrared spectroscopy for de-Tection of lipid-rich and vulnerable plaques. J Nucl Cardiol 2007;14:719-29.
44. Lisauskas JB, Sum ST, Meese TM, Burke AP, Virmani R, Goldstein J, et al. Detection of Lipid Core Coronary Plaques in Autopsy Specimens With a Novel Catheter-Based Near-Infrared Spectroscopy System. JACC Cardiovasc Imaging 2008;1.
45. Waxman S, Dixon SR, Allier PL, Moses JW, Petersen JL, Cutlip D, et al. In Vivo Validation of a Catheter-Based Near-Infrared Spectroscopy System for Detection of Lipid Core Coronary Plaques. JACC Cardiovasc Imaging. 2009;2:858-68.
46. Madder RD, Khan M, Husaini M, Chi M, Dionne S, Vanoosterhout S, et al. Combined near-infrared spectroscopy and intravascular ultrasound imaging of pre-existing coronary artery stents: Can near-infrared spectroscopy reliably detect neoatherosclerosis? Circ Cardiovasc Imaging 2016;9.
47. Jaffer FA, Vinegoni C, John MC, Aikawa E, Gold HK, Finn AV, et al. Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis. Circulation 2008;118:1802-9.
48. Jaffer FA, Calfon MA, Rosenthal A, Mallas G, Razansky RN, Mauskapf A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol 2011;57:2516-26.
49. Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-Activatable fluorescence sensor. Circulation 2007;115:2292-8.
50. Kim JB, Park K, Ryu J, Lee JJ, Lee MW, Cho HS, et al. Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors. Sci Rep 2016;6:22608.
51. Wang H, Gardecki JA, Ughi GJ, Jacques PV, Hamidi E, Tearney GJ. Ex vivo catheter-based imaging of coronary atherosclerosis using multimodality OCT and NIRAF excited at 633 nm. Biomed Opt Express 2015;6:1363.
52. Vinegoni C, Botnaru I, Aikawa E, Calfon MA, Iwamoto Y, Folco EJ, et al. Indocyanine Green Enables Near-Infrared Fluorescence Imaging of Lipid-Rich, Inflamed Atherosclerotic Plaques. Sci Transl Med 2011;3:84ra45-84ra45.
53. Abran M, Stähli BE, Merlet N, Mihalache-Avram T, Mecteau M, Rhéaume E, et al. Validating a bimodal intravascular ultrasound (IVUS) and near-infrared fluorescence (NIRF) catheter for atherosclerotic plaque detection in rabbits. Biomed Opt Express 2015;6:3989.
54. Kim S, Lee MW, Kim TS, Song JW, Nam HS, Cho HS, et al. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-Associated inflammation in a beating coronary artery. Eur Heart J 2016;37:2833-44.
55. Verjans JW, Osborn EA, Ughi GJ, Calfon Press MA, Hamidi E, Antoniadis AP, et al. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green. JACC Cardiovasc Imaging 2016;9:1087-95;
56. Bozhko D, Osborn EA, Rosenthal A, Verjans JW, Hara T, Kellnberger S, et al. Quantitative intravascular biological fluorescence-ultrasound imaging of coronary and peripheral arteries in vivo. Eur Heart J Cardiovasc Imaging 2017;18:1253-61.